Catalyst Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-65
Closed -$23K 504
2017
Q1
$23K Buy
+65
New +$5.12K ﹤0.01% 358
2016
Q1
Sell
-1,387
Closed -$339K 513
2015
Q4
$339K Buy
1,387
+1,375
+11,458% +$117K 0.05% 217
2015
Q3
$2K Hold
12
﹤0.01% 520
2015
Q2
$5K Buy
+12
New +$1.06K ﹤0.01% 449

Other funds holding CAH

Catalyst Capital Advisors's CAH Position: Q2 2026 in Review

Catalyst Capital Advisors reduced its Cardinal Health (CAH) stake by 2.4% in Q2 2026, selling an estimated $98.7K and leaving 19,150 shares worth $4.55M. The position accounts for 0.08% of the portfolio, ranked #71.

Catalyst Capital Advisors first reported a position in CAH in Q2 2013 and has held it in 14 quarters since. The position peaked at $11.5M in Q4 2015. 412 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Catalyst Capital Advisors held 19,150 shares of Cardinal Health worth $4.55M as of Q2 2026.
  • Catalyst Capital Advisors sold 475 Cardinal Health shares in Q2 2026, an estimated $98.7K.
  • Cardinal Health made up 0.08% of Catalyst Capital Advisors's portfolio in Q2 2026, its #71 holding.
  • Catalyst Capital Advisors first reported a position in Cardinal Health in Q2 2013 and has held it in 14 quarters since.
  • Catalyst Capital Advisors's Cardinal Health position peaked at $11.5M in Q4 2015.
  • 412 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.